Abivax (ABVX) has an average rating of buy and mean price target of $162.06, according to analysts polled by FactSet.
What else is happening in Research?
Research
UBS Downgrades Revvity to Neutral From Buy, Adjusts Price Target to $140 From $120
Revvity (RVTY) has an average rating of overweight and mean price target of $127.29, according to analysts polled by FactSet.
$RVTY
Research
UBS Downgrades Mettler-Toledo International to Neutral From Buy, Adjusts Price Target to $1,460 From $1,650
Mettler-Toledo International (MTD) has an average rating of hold and mean price target of $1,472.92, according to analysts polled by FactSet.
$MTD
Research
UBS Downgrades Agilent Technologies to Neutral From Buy, $165 Price Target
Agilent Technologies (A) has an average rating of overweight and mean price target of $175.58, according to analysts polled by FactSet.
$A